A Cross-National Comparison of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome at Tertiary Care Settings from the US and Spain.
Bhatia, Shaun, Olczyk, Nicole, Jason, Leonard A et al. · American journal of social sciences and humanities · 2020 · DOI
Quick Summary
This study compared ME/CFS patients in the United States and Spain to see if the disease affects people differently depending on where they live. Researchers found that Spanish patients reported worse overall health and more severe symptoms, particularly pain and hormone-related problems, compared to American patients. The differences may be due to how each country handles disability benefits, how doctors view ME/CFS, and how easily patients can see specialists.
Why It Matters
Understanding how ME/CFS manifests across different healthcare systems and cultures can help researchers identify whether observed differences are disease-related or influenced by social and medical factors. This knowledge may improve international clinical standards and highlight the importance of culturally-sensitive healthcare approaches for ME/CFS patients worldwide.
Observed Findings
Spanish patients scored significantly lower than US patients on five SF-36 domains: physical functioning, bodily pain, general health, role emotional, and mental health
Spanish patients reported more symptoms across all DePaul Symptom Questionnaire items
Pain and neuroendocrine symptoms showed the largest differences between Spanish and US populations
Both samples met the same Fukuda diagnostic criteria, yet reported different symptom severity and functional impairment
Inferred Conclusions
Healthcare system differences, including disability policy frameworks and access to specialist care, may influence patient-reported symptom severity and functional outcomes
Cultural and healthcare perception of ME/CFS may affect how patients experience and report their illness
International comparisons of ME/CFS suggest the need for standardized, culturally-informed assessment approaches
Remaining Questions
Are the observed differences due to actual variation in disease severity or to differences in how patients report symptoms across cultures?
How do disability policies and healthcare system structures specifically impact ME/CFS outcomes and patient-reported symptoms?
Would similar patterns emerge in primary care or community-based samples, or are findings specific to tertiary referral populations?
What This Study Does Not Prove
This study cannot determine whether differences between countries are caused by actual biological disease variation, healthcare system factors, or patient reporting differences. The cross-sectional design shows correlation only, not causation. Additionally, the study was limited to tertiary care settings, so findings may not represent the broader ME/CFS patient populations in either country.